Brevan Howard Capital Management LP Celldex Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 11,414 shares of CLDX stock, worth $228,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,414
Previous 17,815
35.93%
Holding current value
$228,280
Previous $605,000
52.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$180 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$101 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$93.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$77.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$75.1 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $935M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...